by Joris Van Arensbergen | Sep 17, 2025 | Blog, FACE technology, News, SURE Technology
Annogen is launcing its proprietary SuRE™ platform, which is used for functional annotation and improvement of promoters and enhancers, for applications in crop engineering. The powerful platform provides a massive-scale “blueprint” of a crop’s...
by Joris Van Arensbergen | Sep 17, 2025 | Blog, News, SURE Technology
Annogen is thrilled to announce our participation in the upcoming European Society of Gene and Cell Therapy (ESGCT) conference, taking place from October 7th to 10th in beautiful Seville, Spain! As a leading force in advanced therapy innovation, we are eager to...
by Joris Van Arensbergen | Sep 17, 2025 | Blog, News, SURE Technology
Barcelona, The Netherlands – September 10, 2025 Lentitek and Annogen join forces to improve the quality and safety of T-cell therapies. This collaboration, jointly announced at the CGTI Leadership Summit today, aims to improve lentivirus-based CAR-T therapies by...
by Joris Van Arensbergen | Sep 10, 2025 | Blog, News, SURE Technology
Our Chief Strategy Officer Martijn Kelder will be speaking at the Cell and Gene Therapy Innovation Leadership Summit in Barcelona, next Thursday at 15:15. His presentation will reveal Annogen’s latest developments in promoter discovery and characterization, revealing...
by Joris Van Arensbergen | May 12, 2025 | News, SURE Technology
Amsterdam, The Netherlands – May 12, 2025 Orchard Therapeutics, a Kyowa Kirin company focused on innovative gene therapies, and Annogen B.V., experts in bespoke promoter design and gene expression engineering, today announced the successful identification of...
by Joris Van Arensbergen | May 7, 2025 | News, SURE Technology
Amsterdam, The Netherlands – May 7, 2025 Ascend Advanced Therapies and Annogen will combine their expertise in AAV biology, vector manufacturing and genetic engineering to improve the quality of recombinant AAV particles used in gene therapy applications. While AAV...
